These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27259808)

  • 1. Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis.
    Avtanski DB; Nagalingam A; Tomaszewski JE; Risbood P; Difillippantonio MJ; Saxena NK; Malhotra SV; Sharma D
    Mol Oncol; 2016 Aug; 10(7):1118-32. PubMed ID: 27259808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
    PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
    Zhang L; Xu L; Zhang F; Vlashi E
    Cell Cycle; 2017 Apr; 16(8):737-745. PubMed ID: 27753527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zerumbone inhibits epithelial-mesenchymal transition and cancer stem cells properties by inhibiting the β-catenin pathway through miR-200c.
    Dermani FK; Amini R; Saidijam M; Pourjafar M; Saki S; Najafi R
    J Cell Physiol; 2018 Dec; 233(12):9538-9547. PubMed ID: 29943808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.
    Hahn S; Jackstadt R; Siemens H; Hünten S; Hermeking H
    EMBO J; 2013 Nov; 32(23):3079-95. PubMed ID: 24185900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
    Li H; Rokavec M; Jiang L; Horst D; Hermeking H
    Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 Attenuates Oxidative Phosphorylation and Facilitates Cancer Stemness through Downregulating miR-200c-PCK2 Axis in Basal-Like Breast Cancer.
    Chao CH; Wang CY; Wang CH; Chen TW; Hsu HY; Huang HW; Li CW; Mai RT
    Mol Cancer Res; 2021 Nov; 19(11):1900-1916. PubMed ID: 34312289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
    Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Oct; 6(30):29947-62. PubMed ID: 26359358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
    Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
    Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells.
    Turcatel G; Rubin N; El-Hashash A; Warburton D
    PLoS One; 2012; 7(1):e31032. PubMed ID: 22299047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.
    Rokavec M; Öner MG; Li H; Jackstadt R; Jiang L; Lodygin D; Kaller M; Horst D; Ziegler PK; Schwitalla S; Slotta-Huspenina J; Bader FG; Greten FR; Hermeking H
    J Clin Invest; 2014 Apr; 124(4):1853-67. PubMed ID: 24642471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J; Liang S; Duan X
    J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.